Clinical applications of genetic rearrangements in cancer

Seminars in Cancer Biology

Volumn 7, Issue 1, 1996, Pages 25-32

  Sheer, Denise ^b   Squire, Jeremy ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Diagnosis; Genetic aberrations; Prognosis; Residual disease; Therapy

Indexed keywords

TUMOR MARKER;

CANCER DIAGNOSIS; CANCER GENETICS; CHROMOSOME ABERRATION; CYTOGENETICS; GENETIC MARKER; HUMAN; METHODOLOGY; PROGNOSIS; REVIEW; SOMATIC MUTATION;

EID: 0029998752     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0004     Document Type: Review

References (34)

1. Grompe M (1993) The rapid detection of unknown mutations in nucleic acids. Nat Genet 5:111-117
2. Rooney DE, Czepulkowski BH (1992) Human Cytogenetics. A Practical Approach, Volumes I and II. Oxford University Press, Oxford
3. McPherson MJ, Quirke P, Taylor GR (1991) PCR: A Practical Approach. IRL Press, Oxford
4. Hogge DE (1994) Cytogenetics and oncogenes in leukemia. Curr Opin Oncol 6:3-13
5. Raimondi SC (1993). Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81:2237-2251
6. Beishuizen A, Verhoeven MA, Mol EJ, Breit TM, Wolvers-Tettero IL, van-Dongen JJ (1993) Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia 7:2045-2053
7. Breit TM, Wolvers-Tettero IL, Beishuizen A, Verhoeven MA, van-Wering ER, van-Dongen JJ (1993) Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia. Blood 82:3063-3074
8. Sorensen PHB, Triche TJ (1996) Gene fusions encoding chimaeric transcription factors in solid tumors. Semin Cancer Biol 7:3-14
9. Ilson DH, Motzer RJ, Rodriguez E, Chaganti RS, Bosl GJ (1993) Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site. Semin Oncol 20:229-237
10. Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RSK (1994) Chromosomal aberrations in soft tissue tumors relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 144:1121-1134
11. Rodriguez E, Sreekantaiah C, Chaganti RSK (1994) Genetic changes in epithelial solid neoplasia. Cancer Res 54:3398-3406
12. Taylor CPF, Patel K, Jones T, Kiely F, De-Stavola BL, Sheer D (1993) Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of t(11;22) using fluorescence in situ hybridisation. Br J Cancer 67:128-133
13. Mertens F, Mandahl N, Mitelman F, Heim S (1994) Cytogenetic analysis in the examination of solid tumors in children. Pediatr Hematol Oncol 11:361-377
14. Delattre O, Zucman J, Ploustagel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G (1992) Gene fusion with an ETS DNA binding domain caused by chromosome translocation in human cancers. Nature 359:162-165
15. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, et al (1995) In-vivo amplification of the androgen receptor gene and progression of human prostate-cancer. Nature Genet 9:401-406
16. Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, et al (1992) Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer 70:1685-1694
17. Taylor CPF, McGuckin AG, Bown NP, Reid MM, Malcolm AJ, Pearson ADJ, Sheer D (1994) Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumor imprints and bone marrow smears. Br J Cancer 69:445-451
18. Boerner S, Squire J, Thorner P, McKenna G, Zielenska M (1994) Assessment of MYCN amplification in neuroblastoma biopsies by differential polymerase chain reaction. Pediatr Pathol 14:823-832
19. Campana D, Pui CH (1995) Detection of minimal residual disease in acute leukemia: methodological advances and clinical significance. Blood 85:1416-1434
20. Gribben JG, Saporito L, Barber M, Blake KW, Edwards RM, Griffin JD, et al (1992) Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. Blood 80:1083-1089
21. Miller DR, Coccia PF, Bleyer WA, Lukens JN, Siegel SE, Sather HN, et al (1989)Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol 7:1807-1815
22. Wasserman R, Galili N, Ito Y, Silber JH, Reichard BA, Shane S, et al (1992) Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. J Clin Oncol 10:1879-1888
23. Huang W, Sun GL, Li XS, Cao Q, Lu Y, Jang GS, et al (1993) Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood 82:1264-1269
24. Kusec R, Laczika K, Knobl P, Friedl J, Greinix H, Kahls P, et al (1994) AML1/ ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 8:735-739
25. Cave H, Guidal C, Rohrlich P, Delfau MH, Broyart A, Lescoeur B, et al (1994) Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood 83:1892-1902
26. Yokota S, Hansen-Hagge TE, Ludwig WD, Reiter A, Raghavachar A, Kleihauer E, et al (1991) Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 77:331-339
27. Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S et al (1995) Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 85:2532-2638
28. Cross NCP, Feng L, Chase A, Bungey J, Hughes TP, M GJ (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82:1929-1936
29. Anderson WF (1992) Human gene therapy. Science 256:808-813
30. Miller N, Vile R (1995) Targeted vectors for gene therapy. FASEB J 9:190-199
31. Vile RG, Hart IR (1994) Targeting of cytokine gene expression to malignant melanoma cells using tissue specific promoter sequences. Ann Oncol 4:59-65
32. Whartenby KA, Abboud CN, Marrogi AJ, Ramesh R, Freeman SM (1995) The biology of cancer gene therapy. Lab Invest 72:131-145
33. Mercola D, Cohen JS (1995) Antisense approaches to cancer gene therapy (Review). Cancer Gene Ther 2:47-59
34. Lipshutz RJ, Morris D, Chee E, et al (1995) Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 19:442-447